SEARCH

SEARCH BY CITATION

References

  • 1
    McGrath J A, Ishida-Yamamoto A, O’Grady A et al. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol 1993: 100: 366372.
  • 2
    Christiano A M, Anhalt G, Gibbons S et al. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics 1994: 21: 160168.
  • 3
    Fine J D, Eady R A, Bauer E A et al. Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000: 42: 10511066.
  • 4
    McGrath J A, Schofield O M, Eady R A. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol 1994: 130: 617625.
  • 5
    Kon A, Pulkkinen L, Ishida-Yamamoto A et al. Novel COL7A1 mutations in dystrophic forms of epidermolysis bullosa. J Invest Dermatol 1998: 111: 534537.
  • 6
    Christiano A M, Lee J Y, Chen W J et al. Pretibial epidermolysis bullosa: genetic linkage to COL7A1 and identification of a glycine-to-cysteine substitution in the triple-helical domain of type VII collagen. Hum Mol Genet 1995: 4: 15791583.
  • 7
    Mellerio J E, Ashton G H, Mohammedi R et al. Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol 1999: 112: 984987.
  • 8
    Gardella R, Castiglia D, Posteraro P et al. Genotype-phenotype correlation in Italian patients with dystrophic epidermolysis bullosa. J Invest Dermatol 2002: 119: 14561462.
  • 9
    Hammami-Hauasli N, Raghunath M, Kuster W et al. Transient bullous dermolysis of the newborn associated with compound heterozygosity for recessive and dominant COL7A1 mutations. J Invest Dermatol 1998: 111: 12141219.
  • 10
    Ryynanen M, Knowlton R G, Parente M G et al. Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa. Am J Hum Genet 1991: 49: 797803.
  • 11
    Hovnanian A, Duquesnoy P, Blanchet-Bardon C et al. Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest 1992: 90: 10321036.
  • 12
    Christiano A M, Greenspan D S, Lee S et al. Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem 1994: 269: 2025620262.
  • 13
    Christiano A M, Hoffman G G, Chung-Honet L C et al. Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics 1994: 21: 169179.
  • 14
    Sakai L Y, Keene D R, Morris N P et al. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 1986: 103: 15771586.
  • 15
    Burgeson R E. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993: 101: 252255.
  • 16
    Ruoslahti E, Pierschbacher M D. New perspectives in cell adhesion: RGD and integrins. Science 1987: 238: 491497.
  • 17
    Greenspan D S. The carboxyl-terminal half of type VII collagen, including the non-collagenous NC-2 domain and intron/exon organization of the corresponding region of the COL7A1 gene. Hum Mol Genet 1993: 2: 273278.
  • 18
    Lunstrum G P, Kuo H J, Rosenbaum L M et al. Anchoring fibrils contain the carboxyl-terminal globular domain of type VII procollagen, but lack the amino-terminal globular domain. J Biol Chem 1987: 262: 1370613712.
  • 19
    Hammami-Hauasli N, Schumann H, Raghunath M et al. Some, but not all glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils, and skin blistering. J Biol Chem 1998: 273: 1922819234.
  • 20
    Whittock N V, Ashton G H, Mohammedi R et al. Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. J Invest Dermatol 1999: 113: 673686.
  • 21
    Couttet P, Grange T. Premature termination codons enhance mRNA decapping in human cells. Nucleic Acids Res 2004: 32: 488494.
  • 22
    Christiano A M, McGrath J A, Tan K C et al. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am J Hum Genet 1996: 58: 671681.
  • 23
    Dunnill M G, McGrath J A, Richards A J et al. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996: 107: 171177.
  • 24
    Bruckner-Tuderman L, Nilssen O, Zimmermann D R et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 1995: 131: 551559.
  • 25
    Kern J S, Kohlhase J, Bruckner-Tuderman L et al. Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 2006: 126: 10061012.
  • 26
    Sawamura D, Goto M, Yasukawa K et al. Genetic studies of 20 Japanese families of dystrophic epidermolysis bullosa. J Hum Genet 2005: 50: 543546.
  • 27
    Christiano A M, McGrath J A, Uitto J. Influence of the second COL7A1 mutation in determining the phenotypic severity of recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996: 106: 766770.
  • 28
    Hovnanian A, Rochat A, Bodemer C et al. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am J Hum Genet 1997: 61: 599610.
  • 29
    Ryoo Y W, Kim B C, Lee K S. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients. J Dermatol Sci 2001: 26: 125132.
  • 30
    Jarvikallio A, Pulkkinen L, Uitto J. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 1997: 10: 338347.
  • 31
    Kivirikko S, Li K, Christiano A M et al. Cloning of mouse type VII collagen reveals evolutionary conservation of functional protein domains and genomic organization. J Invest Dermatol 1996: 106: 13001306.
  • 32
    Wessagowit V, Kim S C, Woong Oh S et al. Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense does not make sense. J Invest Dermatol 2005: 124: 863866.
  • 33
    Titeux M, Mejia J E, Mejlumian L et al. Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicing. Hum Mutat 2006: 27: 291292.
  • 34
    Bruckner-Tuderman L. Epidermolysis bullosa. In: RoyceP M, SteinmannB, eds. Connective Tissue and its Heritable Disorders Molecular, Genetic and Medical Aspects. New York: Wiley-Liss, 1993: 507532.
  • 35
    Christiano A M, Uitto J. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp Dermatol 1996: 5: 111.
  • 36
    Fine J D, Johnson L B, Cronce D et al. Intracytoplasmic retention of type VII collagen and dominant dystrophic epidermolysis bullosa: reversal of defect following cessation of or marked improvement in disease activity. J Invest Dermatol 1993: 101: 232236.
  • 37
    Hashimoto K, Eng A M. Transient bullous dermolysis of the newborn. Retention of anchoring fibril- and basal lamina-like structures in keratinocytes and evidence of collagenolysis. J Cutan Pathol 1992: 19: 496501.
  • 38
    Rodeck U, Fertala A, Uitto J. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Exp Dermatol 2007: 16: 465467.
  • 39
    Sakuntabhai A, Hammami-Hauasli N, Bodemer C et al. Deletions within COL7A1 exons distant from consensus splice sites alter splicing and produce shortened polypeptides in dominant dystrophic epidermolysis bullosa. Am J Hum Genet 1998: 63: 737748.
  • 40
    Posteraro P, Pascucci M, Colombi M et al. Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa. Biochem Biophys Res Commun 2005: 338: 13911401.
  • 41
    Cserhalmi-Friedman P B, McGrath J A, Mellerio J E et al. Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene. Lab Invest 1998: 78: 14831492.
  • 42
    Christiano A M, Fine J D, Uitto J. Genetic basis of dominantly inherited transient bullous dermolysis of the newborn: a splice site mutation in the type VII collagen gene. J Invest Dermatol 1997: 109: 811814.
  • 43
    Jiang W, Bu D, Yang Y et al. A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa. Acta Derm Venereol 2002: 82: 187191.
  • 44
    Pulkkinen L, Uitto J. Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol 1999: 18: 2942.
  • 45
    Sato-Matsumura K C, Yasukawa K, Tomita Y et al. Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa. Arch Dermatol 2002: 138: 269271.
  • 46
    Shimizu H, Hammami-Hauasli N, Hatta N et al. Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and a moderately severe dystrophic epidermolysis bullosa phenotype. J Invest Dermatol 1999: 113: 419421.
  • 47
    Hanson S G, Fine J D, Levy M L. Three new cases of transient bullous dermolysis of the newborn. J Am Acad Dermatol 1999: 40: 471476.
  • 48
    Fassihi H, Diba V C, Wessagowit V et al. Transient bullous dermolysis of the newborn in three generations. Br J Dermatol 2005: 153: 10581063.
  • 49
    Masunaga T, Shimizu H, Takizawa Y et al. Combination of novel premature termination codon and glycine substitution mutations in COL7A1 leads to moderately severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2000: 114: 204205.
  • 50
    Terracina M, Posteraro P, Schubert M et al. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1998: 111: 744750.
  • 51
    Baker A T, Ramshaw J A M, Chan D et al. Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of exl (I)-chain glycine-to-arginine substitutions. Biochem J 1989: 261: 253257.
  • 52
    Kon A, McGrath J A, Pulkkinen L et al. Glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling. J Invest Dermatol 1997: 108: 224228.
  • 53
    Hashimoto I, Kon A, Tamai K et al. Diagnostic dilemma of “sporadic” cases of dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation? Exp Dermatol 1999: 8: 140142.
  • 54
    Rouan F, Pulkkinen L, Jonkman M F et al. Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling. J Invest Dermatol 1998: 111: 12101213.
  • 55
    Matsuba S, Suga Y, Mayuzumi N et al. A Japanese case of de novo dominant dystrophic epidermolysis bullosa. Clin Exp Dermatol 2002: 27: 5658.
  • 56
    Murata T, Masunaga T, Shimizu H et al. Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa. Arch Dermatol Res 2000: 292: 477481.
  • 57
    Mecklenbeck S, Hammami-Hauasli N, Hopfner B et al. Clustering of COL7A1 mutations in exon 73: implications for mutation analysis in dystrophic epidermolysis bullosa. J Invest Dermatol 1999: 112: 398400.
  • 58
    Kon A, Nomura K, Pulkkinen L et al. Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic. J Invest Dermatol 1997: 109: 684687.
  • 59
    Cserhalmi-Friedman P B, Grossman J, Karpati S et al. Identification of a de novo glycine substitution in the type VII collagen gene in a proband with mild dystrophic epidermolysis bullosa. Exp Dermatol 1999: 8: 143145.
  • 60
    Mellerio J E, Dunnill M G, Allison W et al. Recurrent mutations in the type VII collagen gene (COL7A1) in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1997: 109: 246249.
  • 61
    Salas-Alanis J C, Amaya-Guerra M, McGrath J A. The molecular basis of dystrophic epidermolysis bullosa in Mexico. Int J Dermatol 2000: 39: 436442.
  • 62
    Murata T, Masunaga T, Ishiko A et al. Differences in recurrent COL7A1 mutations in dystrophic epidermolysis bullosa: ethnic-specific and worldwide recurrent mutations. Arch Dermatol Res 2004: 295: 442447.
  • 63
    Csikos M, Szocs H I, Laszik A et al. High frequency of the 425A – >G splice-site mutation and novel mutations of the COL7A1 gene in central Europe: significance for future mutation detection strategies in dystrophic epidermolysis bullosa. Br J Dermatol 2005: 152: 879886.
  • 64
    Tamai K, Murai T, Mayama M et al. Recurrent COL7A1 mutations in Japanese patients with dystrophic epidermolysis bullosa: positional effects of premature termination codon mutations on clinical severity. Japanese Collaborative Study Group on Epidermolysis Bullosa. J Invest Dermatol 1999: 112: 991993.
  • 65
    Dang N N, Klingberg S, Marr P, Murrell D F. Review of Collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals 9 novel COL7A1 variants. J Dermatol Sci 2007: 463: 169178.
  • 66
    Mohammedi R, Mellerio J E, Ashton G H et al. A recurrent COL7A1 mutation, R2814X, in British patients with recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol 1999: 24: 3739.
  • 67
    Brittingham R, Colombo M, Ito H et al. Single amino acid substitutions in procollagen VII affect early stages of assembly of anchoring fibrils. J Biol Chem 2005: 280: 191198.
  • 68
    Titeux M, Pendaries V, Tonasso L et al. A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 2007: 29: 267276.
  • 69
    Chen M, Kasahara N, Keene D R et al. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 2002: 32: 670675.
  • 70
    Gache Y, Baldeschi C, Del Rio M et al. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum Gene Ther 2004: 15: 921933.
  • 71
    Ortiz-Urda S, Thyagarajan B, Keene D R et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med 2002: 8: 11661170.
  • 72
    Wong T, Gammon L, Liu L et al. A single intradermal injection of allogeneic fibroblasts can increase type VII collagen expression in recessive dystrophic epidermolysis bullosa for at last 3 months. J Invest Dermatol 2007: 127: S91.